These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Angiogenesis and ER/PR status in primary breast cancer patients: an analysis of 158 needle core biopsies. Vameşu S. Rom J Morphol Embryol; 2007; 48(1):25-31. PubMed ID: 17502947 [Abstract] [Full Text] [Related]
7. Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C. Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374 [Abstract] [Full Text] [Related]
11. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan. Sharif MA, Mamoon N, Mushtaq S, Khadim MT. J Coll Physicians Surg Pak; 2009 Feb; 19(2):99-103. PubMed ID: 19208313 [Abstract] [Full Text] [Related]
15. Prostate-specific antigen value as a marker in breast cancer. Narita D, Cimpean AM, Anghel A, Raica M. Neoplasma; 2006 Apr; 53(2):161-7. PubMed ID: 16575473 [Abstract] [Full Text] [Related]
16. Oestrogen and progesterone receptors in Nigerian breast cancer: relationship to tumour histopathology and survival of patients. Ikpatt OF, Ndoma-Egba R. Cent Afr J Med; 2003 Apr; 49(11-12):122-6. PubMed ID: 15301464 [Abstract] [Full Text] [Related]
17. Correlation of steroid receptors with histopathologic characteristics in breast carcinoma. Bhatavdekar JM, Trivedi SN, Shah NG, Karelia NH, Patel DD, Giri DD, Patel TB. Neoplasma; 1988 Apr; 35(4):413-23. PubMed ID: 3185838 [Abstract] [Full Text] [Related]